US 11834515
Macrocyclic compounds as proteasome inhibitors
granted A61KA61K38/00A61P
Quick answer
US patent 11834515 (Macrocyclic compounds as proteasome inhibitors) held by Tri-Institutional Therapeutics Discovery Institute, Inc. expires Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Tri-Institutional Therapeutics Discovery Institute, Inc.
- Grant date
- Tue Dec 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K38/00, A61P, A61P29/00, A61P31/00